The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in cutaneous wound healing;Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w gojeniu siȩ ran skóry

Przeglad Dermatologiczny

Volumn 91, Issue 3, 2004, Pages 253-261

  Bogaczewicz, Jarosław ^b   Chodorowska, Grazyna ^a   Krasowska, Dorota ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b NONE

Author keywords

Leg ulcers; Lipodermatosclerosis; Matrix metalloproteinases; Tissue inhibitors of metalloproteinases; Wound healing

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 28; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; KERATINOCYTE; LEG ULCER; LIPODERMATOSCLEROSIS; MACROPHAGE; MYOFIBROBLAST; NEUTROPHIL; REVIEW; SKIN FIBROBLAST; SKIN INJURY; STROMA CELL; WOUND HEALING;

EID: 3142688992     PISSN: 00332526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Singer A.J., Clark R.A.F.: Cutaneous wound healing. New Engl J Med 1999, 341, 738-746.
2. Nagase H., Woessner J.F. Jr: Matrix metalloproteinases. J Biol Chem 1999, 274, 21491-21494.
3. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w twardzinie układowej. Przegl Dermatol 2003, 90, 373-382.
4. Bogaczewicz J., Chodorowska G., Krasowska D.: Rola metaloproteaz macierzy i tkankowych inhibitorów metaloproteaz w progresji nowotworów skóry a nowe strategie farmakologicznej inhibicji metaloproteaz macierzy. Przegl Dermatol 2004, 91, 153-160.
5. Saarialho-Kere U.K., Pentland A.P., Birkedal-Hansen H. i inni: Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 1994, 94, 79-88.
6. Stricklin G.P., Li L., Nanney L.B.: Localization of mRNAs representing interstitial collagenase, 72-kda gelatinase, and TIMP in healing porcine burn wounds. J Invest Dermatol 1994, 103, 352-358.
7. Okada A., Tomasetto C., Lutz Y. i inni: Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 1997, 137, 67-77.
8. Agren M.S.: Gelatinase activity during wound healing. Br J Dermatol 1994, 131, 634-640.
9. Saarialho-Kere U.K., Crouch E.C., Parks W.C.: Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 1995, 105, 190-196.
10. Vaalamo M., Weckroth M., Puolakkainen P. i inni: Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 1996, 135, 52-59.
11. Saarialho-Kere U.K., Kovacs S.O., Pentland A.P. i inni: Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 1993, 92, 2858-2866.
12. Saarialho-Kere U.K., Kerkela E., Jahkola T. i inni: Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair. J Invest Dermatol 2002, 119, 14-21.
13. Armstrong D.G.: The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc 2002, 92, 12-18.
14. Pilcher B.K., Dumin J.A., Sudbeck B.D. i inni: The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 1997, 137, 1445-1457.
15. Sudbeck B.D., Pilcher B.K., Welgus H.G. i inni: Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J Biol Chem 1997, 272, 22103-22110.
16. Librach C.L., Werb Z., Fitzgerald M.L. i inni: 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991, 113, 437-449.
17. Fisher C., Gilbertson-Beadling S., Powers E.A. i inni: Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994, 162, 499-510.
18. Shipley J.M., Wesselschmidt R.L., Kobayashi D.K. i innh: Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci USA 1996, 93, 3942-3946.
19. Inoue M., Kratz G., Haegerstrand A. i inni: Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol 1995, 104, 479-483.
20. Madlener M., Mauch C., Conca W. i inni: Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. Biochem J 1996, 320, 659-664.
21. Lohi J., Wilson C.L., Roby J.D. i inni: Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 2001, 276, 10134-10144.
22. Stricklin G.P., Nanney L.B.: Immunolocalization of collagenase and TIMP in healing human burn wounds. J Invest Dermatol 1994, 103, 488-492.
23. Madlener M., Parks W.C., Werner S.: Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 1998, 242, 201-210.
24. Norgauer J., Hildenbrand T., Idzko M. i inni: Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metal loproteinases in venous leg ulcers. Br J Dermatol 2002, 147, 1180-1186.
25. Hasty K.A., Pourmotabbed T.F., Goldberg G.I. i inni: Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 1990, 265, 11421-11424.
26. Stahle-Backdahl M., Parks W.C.: 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol 1993, 142, 995-1000.
27. Saarialho-Kere U.K., Chang E.S., Welgus H.G. i inni: Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest 1992, 90, 1952-1957.
28. Vaalamo M., Leivo T., Saarialho-Kere U.K.: Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 1999, 30, 795-802.
29. Herouy Y., May A.E., Pornschtegel G. i inni: Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: Implications for venous ulcer formation. J Invest Dermatol 1998, 111, 822-827.
30. Wysocki A.B., Staiano-Coico L., Grinnell F.: Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993, 101, 64-68.
31. Weckroth M., Vaheri A., Lauharanta J. i inni: Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 1996, 106, 1119-1124.
32. Kirsner R.S., Pardes J.B., Eaglstein W.H. i inni: The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 1993, 28, 623-627.
33. Neumann H.A.M., Van-den-Broek M.J.T.B.: Increased collagen IV layer in the basal membrane area of the capillaries in severe chronic venous insufficiency. Vasa J Vasc Dis 1991, 20, 26-29.
34. Herrick S.E., Sloan P., McGurk M. i inni: Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 1992, 141, 1085-1095,
35. Senior R.M., Griffin G.L., Fliszar C.J. i inni: Human 92-and 72-kilodalton type IV collagenases are elastases. J Biol Chem 1991, 266, 7870-7875.
36. Higley H.R., Ksander G.A., Gerhardt C.O. i inni: Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration, Br J Dermatol 1995, 132, 79-85.
37. Overall C.M., Wrana J.L., Sodek J.: Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-betal in human fibroblasts: comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 1991, 266, 14064-14071.
38. Vaalamo M., Mattila L., Johansson N. i inni: Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997, 109, 96-101.
39. Baker E.A., Leaper D.J.: Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Rep Reg 2000, 8, 392-398.
40. Bullen E.C., Longaker M.T., Updike D.L. i inni: Tissue inhibitor of metalloproteinase-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995, 104, 236-240.
41. Tarlton J.F., Vickery C.J., Leaper D.J. i inni: Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9. Br J Dermatol 1997, 137, 506-516.
42. Klein S.A., Anderson G.L., Kennedy A.B. i inni: The effects of a broad-spectrum matrix metalloproteinase inhibitor on characteristics of wound healing, J Invest Surg 2002, 15, 199-207.